Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)

Next Previous
X
Search
Trial Profile

A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perfluorohexyloctane (Primary)
  • Indications Dry eyes
  • Focus Registrational; Therapeutic Use
  • Acronyms MOJAVE
  • Sponsors Bausch & Lomb

    • Most Recent Events

    • 28 May 2024 According to a Bausch & Lomb media release, data from this study will be presented during the American Optometric Association (AOA) Optometry's Meeting ePoster Session, taking place virtually May 29-30, 2024.
    • 01 Aug 2023 Results assessing efficacy and safety of NOV03 in adults with DED associated with MGD published in the American Journal of Ophthalmology
    • 08 Jun 2023 According to a Bausch & Lomb media release, data from this study will be presented during the American Optometric Association (AOA) Optometrys Meeting e-posters Virtual Event,

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top